SPA
GOSS icon

Sherbrooke Park Advisers’s Gossamer Bio GOSS Stock Holding History

Sherbrooke Park Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$41.4K Buy
+13,347
New +$38.1K 0.11% 177

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Sherbrooke Park Advisers's GOSS Position: Q4 2025 in Review

Sherbrooke Park Advisers opened a new position in Gossamer Bio (GOSS) in Q4 2025: 13,347 shares worth $41.4K. The stake represents 0.11% of the portfolio and ranks #177 among its holdings.

195 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • Sherbrooke Park Advisers held 13,347 shares of Gossamer Bio worth $41.4K as of Q4 2025.
  • Gossamer Bio was a new Sherbrooke Park Advisers position in Q4 2025.
  • Gossamer Bio made up 0.11% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #177 holding.
  • 195 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.